Meeting Overview - The second meeting of the supervisory board of Nanjing Mailland Medical Technology Co., Ltd. was held on August 25, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1] Financial Report Approval - The supervisory board approved the 2025 semi-annual report, affirming that the report's preparation and review processes adhered to legal requirements and accurately reflected the company's financial status and operational results [1] - The board ensured that there were no violations of confidentiality during the report's preparation [1] Fund Management Report - The board approved the special report on the storage and use of raised funds, confirming compliance with relevant regulations and that the actual use of funds matched previously disclosed information [2] Auditor Appointment - The board approved the reappointment of Zhongxinghua Accounting Firm, confirming its qualifications and ability to meet the company's auditing needs for the 2025 fiscal year [3] Related Party Transactions - The board approved an increase in the estimated amount for daily related party transactions for 2025, stating that it aligns with the company's operational needs and does not harm shareholder interests [4] Fund Replacement Proposal - The board approved a proposal to use self-raised funds for project payments, which will later be replaced with raised funds, enhancing operational efficiency without altering the intended use of raised funds [5] Governance Changes - The board approved the cancellation of the supervisory board and amendments to the company’s articles of association, aiming to improve governance in line with legal requirements [6]
麦澜德: 第二届监事会第十三次会议决议公告